A recent clinical trial has found that in patients with T2DM, tirzepatide performed better than GLP1RAs and dulaglutide monotherapy regarding glycaemic management and body weight reduction
Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations
now Im more relaxed and focus on whole foods, home cooking, and balance
For further reading on how tirzepatides metabolic protection differs from traditional dieting, see TRT Nations post: How Tirzepatide Differs from Traditional Weight Loss Methods: The Metabolic Protection Revolution
They cant always be completely avoided, but you can reduce them by: Starting with a low dose Eating smaller meals Avoiding oily or heavy foods Staying hydrated Dr
A new proprietary study from Acosta Group makes clear that food retailers, CPG brands, and restaurants cant afford to ignore it